Uterine Morcellation for Presumed Leiomyomas
- 1 March 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 137 (3) , e63-e74
Abstract
Morcellation is a surgical technique used to reduce the size of the uterus or myomas by creating smaller pieces to allow the tissue to be removed through small incisions or with laparoscopic instruments. Open (uncontained) morcellation of the uterus and myomas has been scrutinized because of the possible spread of an unsuspected leiomyosarcoma while using a power morcellator during a hysterectomy or myomectomy for presumed symptomatic uterine leiomyomas. Before considering morcellation of the uterus, a woman should be evaluated to determine if she is at increased risk of malignancy of the uterine corpus. Morcellation of a malignancy is contraindicated and women should be evaluated preoperatively to identify malignancy. However, leiomyosarcoma cannot be reliably diagnosed preoperatively; thus, there is a risk that a woman with a presumed leiomyoma may have a malignancy that may be spread through morcellation, leading to a potentially worsened prognosis. Although an abdominal hysterectomy or myomectomy may reduce the chance of spreading cancer cells in women with undiagnosed leiomyosarcoma, it is associated with increased morbidity when compared with minimally invasive approaches. The obstetrician–gynecologist and patient should engage in shared decision making, including informed consent, explaining the risks and benefits of each approach to surgery for presumed leiomyomas, the risks and benefits of morcellation, and alternatives to morcellation.Keywords
This publication has 50 references indexed in Scilit:
- Hand-Assisted Approach to Laparoscopic Myomectomy and HysterectomyJournal of Minimally Invasive Gynecology, 2013
- Complications of HysterectomyObstetrics & Gynecology, 2013
- Abdominal versus laparoscopic hysterectomies for benign diseases: evaluation of morbidity and mortality among 465,798 casesGynecological Surgery, 2013
- Practice Bulletin No. 128Obstetrics & Gynecology, 2012
- Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastomaGynecologic Oncology, 2012
- ACOG Committee Opinion No. 439: Informed ConsentObstetrics & Gynecology, 2009
- Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign diseaseInternational Journal of Gynecological Cancer, 2008
- The risk of developing uterine sarcoma after tamoxifen useInternational Journal of Gynecological Cancer, 2008
- SarcomaMayo Clinic Proceedings, 2007
- Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 casesInternational Journal of Cancer, 2006